[DOI] [PubMed] [Google Scholar] 263.Sugimoto K, Hanai H, Tozawa K, Aoshi T, Uchijima M, Nagata T, et al
A new federal multidistrict litigation docket has been established to centralize lawsuits alleging that glucagonlike peptide1 (GLP1) receptor agonist drugs, including Ozempic, Wegovy, Rybelsus, Mounjaro, and others, caused serious vision loss linked to nonarteritic anterior ischemic optic neuropathy (NAION)
So they just get a lot of it
If you occasionally need to move your injection forward or backward by one day, document the change so you remember when your next dose is actually due
There have been no major pharmacologic interactions for GLP-1 RAs when used with commonly used systemic psoriasis therapies, including methotrexate, cyclosporine, and biologics, according to the statement